benzalkonium chloride 1.3 MG/ML Topical Solution [Releev Cold Sore]
- RxCUI
- 1095485
- RxNorm name
- benzalkonium chloride 1.3 MG/ML Topical Solution [Releev Cold Sore]
- Term type
- SBD
- Status
- Active
- Updated
- 2026-07-30 22:47:53
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052011
- Active start
- 052011
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| benzalkonium chloride | 1.3 MG / 1 ML | benzalkonium | benzalkonium chloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Solution | 316986 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzalkonium | 1378 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | Releev Cold Sore 0.13 % Topical Solution | 1 | NAMES |
| RxNorm Name | benzalkonium chloride 1.3 MG/ML Topical Solution [Releev Cold Sore] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 1 | CODES |
| RxCUI | 1095485 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 63287-419-01 | 63287-419 | RELEEV Cold Sore Treatment Benzalkonium Chloride | Merix Pharmaceutical Corp. | M003 |
| 63287-419-06 | 63287-419 | RELEEV Cold Sore Treatment Benzalkonium Chloride | Merix Pharmaceutical Corp. | M003 |
| 63287-419-20 | 63287-419 | RELEEV Cold Sore Treatment Benzalkonium Chloride | Merix Pharmaceutical Corp. | M003 |
| 63287-419-33 | 63287-419 | RELEEV Cold Sore Treatment Benzalkonium Chloride | Merix Pharmaceutical Corp. | M003 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RELEEV Cold Sore Treatment | BENZALKONIUM CHLORIDE | Merix Pharmaceutical Corp. | fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | 2026-02-02 | Warnings | 63287-419-06 63287-419-33 63287-419-20 63287-419-01 63287-419 63287041920 63287041901 63287041933 63287041906 63287041903 1095485 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | Releev Cold Sore 0.13 % Topical Solution [PSN] · benzalkonium chloride 1.3 MG/ML Topical Solution [Releev Cold Sore] [SBD] · Releev Cold Sore 0.13 % Topical Solution [SY] · Releev Cold Sore 1.3 MG/ML Topical Solution [SY] | 4 | 19 | RELEEV 1 day Cold sore Symptom Treatment | 20260202 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf | RELEEV 1 day Cold sore Symptom Treatment | Merix Pharmaceutical Corp. | 20260202 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R02AA | Antiseptics | ATC1-4 | benzalkonium | |
| ATC | D09AA | Medicated dressings with antiinfectives | ATC1-4 | benzalkonium | |
| ATC | D08AJ | Quaternary ammonium compounds | ATC1-4 | benzalkonium | |
| MEDRT | D001548 | Benzalkonium Compounds | CHEM | has_ingredient | benzalkonium |
| MEDRT | D001548 | Benzalkonium Compounds | CHEM | has_ingredient | benzalkonium chloride |
| MEDRT | D001424 | Bacterial Infections | DISEASE | may_prevent | benzalkonium |
| MEDRT | D001424 | Bacterial Infections | DISEASE | may_prevent | benzalkonium chloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzalkonium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzalkonium chloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | ACTIVATED | 04/28/2026 |
| ATTRIBUTES | ACTIVATED | 07/26/2022 |
| ATTRIBUTES | AVAILABLE_STRENGTH | 1.3 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | Releev Cold Sore 0.13 % Topical Solution |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |